Insiders · Profile

BEHRENS M KATHLEEN

Director at Sarepta Therapeutics. Filing since 6 Apr 2011. CIK 0001211701

Company
Date
Role
Action
Shares
Amount
Of holding
10 Mar 2021
Director
Sold, plan not stated
5,000
$428.80K
3.7%
6 Sep 2019
Director
Bought
2,500
$219.95K
2.0%
31 Oct 2018
Director
Sold, plan not stated
10,000
$1.32M
7.9%
16 Mar 2016
Director
Bought
10,000
$145.43K
84.4%
14 Mar 2016
Director
Bought
65,000
$1.08M
138%
16 Sep 2013
Director
Bought
6,500
$240.78K
17.3%
7 Sep 2012
Director
Bought
17,500
$257.72K
91.3%
6 Apr 2011
Director
Bought
100,000
$150.00K
×20
8 decisions on file.